Benzinga
17 Oct 2025, 17:47 UTC · 47w ago
Verdict
Headline takes no side. We score JAZZ +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
Which stocks this story touches
More positive than 87% of ticker scores this week
Positive mentions of a promising cancer treatment study and new FDA approval for a lung cancer therapy.
More positive than 74% of ticker scores this week
Despite competition and cyclicality, the article notes a one-year surge in share price and suggests the company is on the right track.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 68% of ticker scores this week
The article suggests the stock may be undervalued with healthy cash flow and significant upside potential as travel recovers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
WSJ
19h ago
+78.6%
Price agrees with the score
$239.72 vs $134.25 close before publication (Oct 16) · not market-adjusted
JAZZ chart →
